7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Acromegaly D000172 6 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Actinomycosis D000196 2 associated lipids
Addison Disease D000224 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Angina, Unstable D000789 14 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Koch FP et al. Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. 2012 Clin Oral Investig pmid:20938793
Funck-Brentano T et al. Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism. 2012 PLoS ONE pmid:22432033
Bilgir O et al. Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, D-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever. 2012 Transfus. Apher. Sci. pmid:22079264
Rojano-Mejía D et al. TNFRSF11B gene haplotype and its association with bone mineral density variations in postmenopausal Mexican-Mestizo women. 2012 Maturitas pmid:22079369
Pineda B et al. Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. 2012 Menopause pmid:22067277
Chuang FH et al. Long-term sequential receptor activator of NF-κB ligand (RANKL) and osteoprotegrin (OPG) expression in lipopolysaccharide-induced rat periapical lesions. 2012 J. Oral Pathol. Med. pmid:21793936
Rodriguez-Lorenzo LM et al. Feasibility of ceramic-polymer composite cryogels as scaffolds for bone tissue engineering. 2012 J Tissue Eng Regen Med pmid:21800433
Gimenez-Maitre A et al. Deficit of osteoprotegerin release by osteoblasts from a patient with cystic fibrosis. 2012 Eur. Respir. J. pmid:22379154
Mao X et al. Protection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivo. 2012 Inflammation pmid:22391745
Kim H et al. Association between endometriosis and polymorphisms in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), TRAIL receptor and osteoprotegerin genes and their serum levels. 2012 Arch. Gynecol. Obstet. pmid:22392486
Liu S et al. Effect of simvastatin on the osteogenetic behavior of alveolar osteoblasts and periodontal ligament cells. 2012 Hum. Cell pmid:22399266
Zhao NN et al. [Indication of osteoprotegerin (OPG) and receptor activator of nuclear factor kappa B ligand (RANKL) in gingival crevicular fluid to remodeling of alveolar bone during retention]. 2012 Beijing Da Xue Xue Bao pmid:22353912
Zupan J et al. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. 2012 J. Biomed. Sci. pmid:22380539
Nonaka CF et al. Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts. 2012 Arch. Oral Biol. pmid:21871606
Zheleznyak A et al. Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. 2012 Mol Imaging Biol pmid:21853370
Dorota DK et al. The concentrations of markers of bone turnover in normal pregnancy and preeclampsia. 2012 Hypertens Pregnancy pmid:20822429
Zhou WJ et al. [Expression of receptor activator of NF-κB ligand and osteoprotegerin in peri-implant tissues during unloading period]. 2012 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:22883830
Mayahara K et al. Osteoblasts stimulate osteoclastogenesis via RANKL expression more strongly than periodontal ligament cells do in response to PGE(2). 2012 Arch. Oral Biol. pmid:22884709
Hosbond SE et al. Osteoprotegerin as a marker of atherosclerosis: a systematic update. 2012 Scand. Cardiovasc. J. pmid:22506827
Li YF et al. The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. 2012 Osteoporos Int pmid:21892678
Ohe JY et al. Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts. 2012 Clin Oral Investig pmid:21938481
Kim EC et al. Lysyl oxidase and the lysyl oxidase-like protein modulate odontoblastic differentiation of human dental pulp cells. 2012 J Endod pmid:22595110
da Silva RA et al. Toll-like receptor 2 knockout mice showed increased periapical lesion size and osteoclast number. 2012 J Endod pmid:22595116
Chen WH et al. Effects of huogu I formula (I) on correlated factors of bone regeneration in chickens with steroid-induced necrosis of femoral head. 2012 Chin J Integr Med pmid:22549392
Zheng D et al. The beneficial effect of Icariin on bone is diminished in osteoprotegerin-deficient mice. 2012 Bone pmid:22551876
Wang YD et al. Selective regulation of osteoblastic OPG and RANKL by dehydroepiandrosterone through activation of the estrogen receptor β-mediated MAPK signaling pathway. 2012 Horm. Metab. Res. pmid:22556124
Larussa T et al. No evidence of circulating autoantibodies against osteoprotegerin in patients with celiac disease. 2012 World J. Gastroenterol. pmid:22529691
Hou JM et al. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22902986
Ma B et al. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. 2012 Acta Pharmacol. Sin. pmid:22426695
Schweikle E et al. Osteoprotegerin positively regulates hematopoietic progenitor cells. 2012 Curr Stem Cell Res Ther pmid:22023625
García-Martín A et al. [Effect of milk product with soy isoflavones on quality of life and bone metabolism in postmenopausal Spanish women: randomized trial]. 2012 Med Clin (Barc) pmid:22024564
Zijlstra WP et al. Cobalt and chromium ions reduce human osteoblast-like cell activity in vitro, reduce the OPG to RANKL ratio, and induce oxidative stress. 2012 J. Orthop. Res. pmid:22025323
Zhao N et al. Effects of local osteoprotegerin gene transfection on orthodontic root resorption during retention: an in vivo micro-CT analysis. 2012 Orthod Craniofac Res pmid:22264323
Erkol A et al. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction. 2012 Atherosclerosis pmid:22265272
Liu T et al. [Correlation between local microenvironment leptin expression and avascular necrosis of the femoral head]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230665
Li L et al. [Progress of osteogenic effect of strontium and its application in orthopaedics]. 2012 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:23230680
Qiu S et al. [Design and activity verification of human parathyroid hormone (1-34) mutant protein]. 2012 Yao Xue Xue Bao pmid:22993856
Vik A et al. Serum osteoprotegerin and future risk of venous thromboembolism. The Tromsø study. 2012 Thromb. Res. pmid:22909822
Dong W et al. [Effect of alendronate on expressions of osteoprotegerin and receptor activator of nuclear factor κB ligand in mouse osteoblasts]. 2012 Nan Fang Yi Ke Da Xue Xue Bao pmid:23268391
Feng Y et al. AMP-activated protein kinase acts as a negative regulator of high glucose-induced RANKL expression in human periodontal ligament cells. 2012 Chin. Med. J. pmid:22964327
Pedersen S et al. Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. 2012 Cardiology pmid:22964478
Bargman R et al. High- and low-dose OPG-Fc cause osteopetrosis-like changes in infant mice. 2012 Pediatr. Res. pmid:22926546
Zheng CM et al. Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients. 2012 Tohoku J. Exp. Med. pmid:22156488
Said F et al. The effect of etidronate on the periodontium of ovariectomized rats. 2012 J. Periodontol. pmid:22166164
Guo D et al. Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. 2012 Mol. Cell. Biochem. pmid:22167620
Svensson M et al. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. 2012 Nephrol. Dial. Transplant. pmid:22172725
Kraus D et al. Intermittent PTH(1-34) signals through protein kinase A to regulate osteoprotegerin production in human periodontal ligament cells in vitro. 2012 Clin Oral Investig pmid:22186940
Zhao N et al. Local osteoprotegerin gene transfer inhibits relapse of orthodontic tooth movement. 2012 Am J Orthod Dentofacial Orthop pmid:22196183
Bilgin E et al. Markers of bone metastases in breast and lung cancers. 2012 Asian Pac. J. Cancer Prev. pmid:23167338
Luo ZR and Xie QJ [Correlation between osteoprotegerin gene 209G/A, 245T/G and 1181G/C polymorphism and acute coronary syndromes in Han people of Fujian area]. 2012 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:23168201
Li YL and Wang H [Serum osteoprotegerin level in children with nephrotic syndrome and the effect of glucocorticoid on it]. 2012 Zhongguo Dang Dai Er Ke Za Zhi pmid:22989431
Tyagi AM et al. Formononetin reverses established osteopenia in adult ovariectomized rats. 2012 Menopause pmid:22781783
Kim IS et al. Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. 2012 J. Dent. Res. pmid:23086742
Xu Y et al. [The function of bushen qiangdu recipe containing serum in OPG/RANKL pathway of ankylosing spondylitis patients]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803436
Zhu XF et al. [Effects of yigu capsule containing serum on the osteoblast differentiation and the expressions of osteoprotegerin and bone morphogenetic protein 2 after treatment by advanced glycation end products in vitro]. 2012 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22803437
Davenport C et al. The effect of exercise on osteoprotegerin and TNF-related apoptosis-inducing ligand in obese patients. 2012 Eur. J. Clin. Invest. pmid:22803952
Mirzaei K et al. Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. 2012 Minerva Med. pmid:22805623
Belibasakis GN and Bostanci N The RANKL-OPG system in clinical periodontology. 2012 J. Clin. Periodontol. pmid:22092994
Ambroszkiewicz J et al. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis]. 2012 Apr-Jun Med Wieku Rozwoj pmid:22971655
Dalezis P et al. Dexamethasone plus octreotide regimen increases anticancer effects of docetaxel on TRAMP-C1 prostate cancer model. 2012 Jan-Feb In Vivo pmid:22210719
Nuño-Arana I et al. Distribution of three SNPs related to low bone mineral density in Amerindian groups and Mestizos from Mexico. 2012 Jul-Aug Am. J. Hum. Biol. pmid:22434650
Varsavsky M et al. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer. 2012 Jul-Aug J. Androl. pmid:21903971
Heitzer E et al. IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. 2012 Nov-Dec Pain Physician pmid:23159968
Giganti MG et al. Changes in serum levels of TNF-alpha, IL-6, OPG, RANKL and their correlation with radiographic and clinical assessment in fragility fractures and high energy fractures. 2012 Oct-Dec J. Biol. Regul. Homeost. Agents pmid:23241117
Umesan UK et al. Assessing salivary biomarkers for analyzing orthodontic tooth movement. 2013 Am J Orthod Dentofacial Orthop pmid:23561400
Flórez-Moreno GA et al. Authors' response. 2013 Am J Orthod Dentofacial Orthop pmid:23561401
Lu L et al. A novel therapeutic strategy for adolescent idiopathic scoliosis based on osteoporotic concept. 2013 Med. Hypotheses pmid:23562283
Fu YX et al. Osteoprotegerin influences the bone resorption activity of osteoclasts. 2013 Int. J. Mol. Med. pmid:23563320
Kadow-Romacker A et al. Effect of β-tricalcium phosphate coated with zoledronic acid on human osteoblasts and human osteoclasts in vitro. 2013 J Biomater Appl pmid:21862509
Takeuchi S et al. Acidosis inhibits mineralization in human osteoblasts. 2013 Calcif. Tissue Int. pmid:23754489
Antonoglou G et al. Serum osteoprotegerin and periodontal destruction in subjects with type 1 diabetes mellitus. 2013 J. Clin. Periodontol. pmid:23758409
Pateinakis P et al. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. 2013 BMC Nephrol pmid:23758931
Mankoč Ramuš S et al. SNP rs2073618 of the osteoprotegerin gene is associated with diabetic retinopathy in Slovenian patients with type 2 diabetes. 2013 Biomed Res Int pmid:24228244
Stalvey MS et al. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. 2013 PLoS ONE pmid:24236172
Zhou J et al. [Effect of osthole on bone metabolism in rat femoral tissues in vitro]. 2013 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:24183047
Jacobs C et al. Osteogenic differentiation of periodontal fibroblasts is dependent on the strength of mechanical strain. 2013 Arch. Oral Biol. pmid:23422327
Joo MK et al. The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats. 2013 Mol Med Rep pmid:23426758
Araújo AA et al. Effect of telmisartan on levels of IL-1, TNF-α, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model. 2013 J. Clin. Periodontol. pmid:24118063
Meneghini M et al. Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation. 2013 Transplantation pmid:23812001
Bao X et al. The effect on proliferation and differentiation of cementoblast by using sclerostin as inhibitor. 2013 Int J Mol Sci pmid:24152444
Prati AJ et al. Release of bone markers in immediately loaded and nonloaded dental implants: a randomized clinical trial. 2013 J. Dent. Res. pmid:24158337
de Araújo Júnior RF et al. Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. 2013 PLoS ONE pmid:23843954
Xiong Q et al. [Effects of recombinant human osteoprotegerin and recombinant RANK protein on the differentiation of osteoclast precursors]. 2013 Zhongguo Gu Shang pmid:23844495
LaCroix AZ et al. OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study. 2013 Bone pmid:23735608
Wulf-Johansson H et al. Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions. 2013 PLoS ONE pmid:24349233
Nehring P et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex‑specific rs2073618 polymorphism as a risk factor for diabetic foot. 2013 Pol. Arch. Med. Wewn. pmid:23299915
Kaludjerovic J and Ward WE Adequate but not supplemental folic acid combined with soy isoflavones during early life improves bone health at adulthood in male mice. 2013 J. Nutr. Biochem. pmid:23643520
Kim JY et al. Osteoprotegerin causes apoptosis of endothelial progenitor cells by induction of oxidative stress. 2013 Arthritis Rheum. pmid:23666878
Marano RJ et al. Prolactin expression in the cochlea of aged BALB/c mice is gender biased and correlates to loss of bone mineral density and hearing loss. 2013 PLoS ONE pmid:23667691
Hemingway F et al. Investigation of osteoclastogenic signalling of the RANKL substitute LIGHT. 2013 Exp. Mol. Pathol. pmid:23391709
Kuriwaka-Kido R et al. Parathyroid hormone (1-34) counteracts the suppression of interleukin-11 expression by glucocorticoid in murine osteoblasts: a possible mechanism for stimulating osteoblast differentiation against glucocorticoid excess. 2013 Endocrinology pmid:23397032
Manfrin TM et al. Expression of OPG, RANK, and RANKL proteins in tooth repair processes after immediate and delayed tooth. 2013 J Craniofac Surg pmid:23348347
Zhou J et al. Pulsed electromagnetic field stimulates osteoprotegerin and reduces RANKL expression in ovariectomized rats. 2013 Rheumatol. Int. pmid:22948539
Saito K et al. Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. 2013 PLoS ONE pmid:23349978
Keller KK et al. SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes. 2013 Rheumatol. Int. pmid:22948540
Belaya ZE et al. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome. 2013 Osteoporos Int pmid:23358608
Pamuk BO et al. Evaluation of circulating endothelial biomarkers in familial Mediterranean fever. 2013 Rheumatol. Int. pmid:23358733
Ney JT et al. Genetic polymorphism of the OPG gene associated with breast cancer. 2013 BMC Cancer pmid:23369128
Sottnik JL and Keller ET Understanding and targeting osteoclastic activity in prostate cancer bone metastases. 2013 Curr. Mol. Med. pmid:23061677
Kerschan-Schindl K Bone turnover in hyperparathyroidism. 2013 Wien Med Wochenschr pmid:22805761

Table of Content